Managing the Heart: Sick Sinus Syndrome and Pacemakers

In CAID syndrome, the heart and the gut share a common underlying genetic cause. While the gut issues often take center stage in childhood, the heart’s natural pacemaker is also vulnerable. Managing the heart in CAID is about proactive, individualized monitoring to ensure the heart’s rhythm remains stable over time.

The Presentation of Heart Rhythm Issues

The cardiac part of CAID is most commonly characterized by the SGO1 mutation’s effect on the heart’s electrical pacing ^[1]. While evidence is based on small cohort data and individual cases, the rhythm changes often involve:

1. Sick Sinus Syndrome (SSS): This is frequently the first cardiac sign. The sinus node—the heart’s natural pacemaker—fails to fire correctly. This leads to a heart rate that is inappropriately slow (bradycardia), long pauses between beats, or an inability for the heart rate to speed up adequately during exercise ^[2][3].
2. Atrial Flutter: Patients may also develop atrial flutter, a rapid, organized abnormal rhythm in the upper chambers of the heart ^[4]. Atrial flutter may cause palpitations, breathlessness, or reduced exercise tolerance.

Because rhythm changes can sometimes happen silently, specialists typically recommend regular monitoring. An individualized surveillance plan—often involving periodic Holter monitors (portable EKG devices) or remote device checks—is essential to catch these shifts ^[2].

The Role of Pacemakers and Arrhythmia Treatment

When sick sinus syndrome causes significant symptoms, pacing therapy is generally required. In one pediatric study of eight CAID patients, every patient who developed sinus dysfunction eventually required a permanent pacemaker ^[2].

• What Pacemakers Do: A pacemaker is recommended when sick sinus syndrome causes symptoms like fainting (syncope), extreme dizziness, or profound fatigue ^[3][5]. It acts as a backup, ensuring the heart receives electrical signals when the natural rate drops too low. Rate-adaptive pacing can also help the heart speed up during physical activity to match the body’s needs ^[3][6].
• What Pacemakers Do Not Do: A pacemaker treats clinically important sinus-node dysfunction; it does not directly terminate or prevent atrial flutter, nor can device programming prevent all atrial arrhythmias. While symptoms caused by bradycardia (like severe fatigue) may improve after appropriately indicated pacing, it is not a cure-all.
• Managing Atrial Flutter: If atrial flutter develops, it requires separate electrophysiology-directed management. This may include antiarrhythmic medications, a procedure called an ablation, and an individualized assessment of anticoagulation (blood thinners) for stroke risk.

Medication Safety: Coordination is Key

One of the most important aspects of managing CAID is the interaction between gut treatments and heart health. Some medications used to help the intestines move can have side effects on heart rate or rhythm.

• Pyridostigmine (Mestinon): This medication is sometimes used to support gut motility ^[7]. However, it can produce vagal effects and clinically important bradycardia or conduction problems. Cases of severe bradycardia have been reported in CIPO patients taking this drug ^[8][9].
• QT-Prolonging Drugs: Certain medications can change the heart’s electrical reset time (the QT interval).
• Safer Alternatives: Newer drugs like prucalopride have a relatively favorable cardiac and QT profile at approved doses ^[10][11].

A Collaborative Approach: You do not need to avoid all GI medications, but the prescribing clinician, pharmacist, and cardiology team must coordinate whenever a drug can affect heart rate or the QT interval. This includes a medication reconciliation and risk-based review process. Never start, stop, or change doses of antiarrhythmic, anticoagulant, or GI motility medications without your clinicians’ advice ^[12].